Limitations of Current Therapeutic Options, Possible Drug Targets and Scope of Natural Products in Control of Leishmaniasis

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|18|1|26-41

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.18, Iss.1, 2017-12, pp. : 26-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cushing’s syndrome: drug targets and therapeutic options

By Páez-Pereda Marcelo   Arzt Eduardo   Stalla Günter K  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 10, 2002-10 ,pp. : 1537-1546

Informa Healthcare

Access to resources Recommend Favorite

Malaria and Leishmaniasis: Current Status of Chemotherapy, New Leads and Targets for Drug Discovery

By  

Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Infective Agents), Vol. 8, Iss. 3, 2009-07 ,pp. : 226-267

Bentham Science Publishers

Access to resources Recommend Favorite

Current Therapeutics, Their Problems and Thiol Metabolism as Potential Drug Targets in Leishmaniasis

By  

Current Drug Metabolism, Vol. 17, Iss. 9, 2016-11 ,pp. : 897-919

Bentham Science Publishers

Access to resources Recommend Favorite

Current strategies for drug discovery through natural products

By Harvey Alan L   Clark Rachel L   Mackay Simon P   Johnston Blair F  

Expert Opinion on Drug Discovery, Vol. 5, Iss. 6, 2010-06 ,pp. : 559-568

Informa Healthcare

Access to resources Recommend Favorite

Novel natural vanilloid receptor agonists: new therapeutic targets for drug development

By Sterner O.   Szallasi A.  

Trends in Pharmacological Sciences, Vol. 20, Iss. 11, 1999-11 ,pp. : 459-465

Elsevier

Access to resources Recommend Favorite